Differential effect of helicobacter pylori eradication on time-trends in Brady/hypokinesia and rigidity in idiopathic parkinsonism: Report on completion of a randomized, double-blind, placebo-controlled efficacy study

Helicobacter

Volumn 15, Issue 4, 2010, Pages 279-294

  Dobbs, Sylvia M ^a,b   Dobbs, R John ^a,b   Weller, Clive ^a   Charlett, André ^a,c   Bjarnason, Ingvar T ^b   Lawson, Andrew J ^c   Letley, Darren ^d   Harbin, Lucy ^e   Price, Ashley B ^e   Ibrahim, Mohammad A A ^b   Oxlade, Norman L ^a   Bowthorpe, James ^a   Leckstroem, Daniel ^a   Smee, Cori ^a   Plant, J Malcolm ^a   Peterson, Dale W ^f  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^e ST MARK S HOSPITAL   (United Kingdom)

^f UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

anti nuclear antibody; H. pylori eradication; idiopathic parkinsonism; low density infection; small intestinal bacterial overgrowth; treatment failure

Indexed keywords

AMOXICILLIN; ANTINUCLEAR ANTIBODY; ANTIPARKINSON AGENT; CLARITHROMYCIN; HYDROGEN; LACTULOSE; METRONIDAZOLE; OMEPRAZOLE; PLACEBO; RANITIDINE BISMUTH CITRATE; TETRACYCLINE; ANTIINFECTIVE AGENT; ANTIULCER AGENT;

ADULT; ARTICLE; B LYMPHOCYTE; BACTERIAL OVERGROWTH; BODY EQUILIBRIUM; BRADYKINESIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAIRY PRODUCT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TREATMENT FAILURE; ERADICATION THERAPY; FEMALE; GAIT; GENERAL CONDITION DETERIORATION; HAND TREMOR; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDROGEN BREATH TEST; HYPOKINESIA; IDIOPATHIC DISEASE; IMMUNOBLOTTING; IMMUNOHISTOLOGY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NEUTROPHIL; NULL HYPOTHESIS; OUTCOME ASSESSMENT; PARALLEL DESIGN; PARKINSONISM; PATIENT COMPLIANCE; PEPTIC ULCER; PERSISTENT INFECTION; PRIORITY JOURNAL; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; RIGIDITY; STEADY STATE; STOMACH ANTRUM; STOMACH BIOPSY; T LYMPHOCYTE; TORQUE; TREATMENT OUTCOME; TREATMENT RESPONSE; UREA BREATH TEST; WALKING SPEED; AGED; DRUG COMBINATION; DRUG EFFECTS; GENETICS; HELICOBACTER INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PARKINSON DISEASE; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; DRUG THERAPY, COMBINATION; FEMALE; GAIT; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI; PARKINSONIA;

EID: 77954833727     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2010.00768.x     Document Type: Article

References (53)

1. Dobbs SM, Dobbs RJ, Weller C, Charlett A. Link between Helicobacter pylori infection and idiopathic parkinsonism. Med Hypotheses 2000 55 : 93 8.
2. Dobbs RJ, Dobbs SM, Weller C, et al. Helicobacter hypothesis for idiopathic parkinsonism: before and beyond. Helicobacter 2008 13 : 309 322.
3. Charlett A, Dobbs RJ, Dobbs SM, et al. Blood profile holds clues to role of infection in a premonitory state for idiopathic parkinsonism and of gastrointestinal infection in established disease. Gut Pathogens 2009 1 : 20.
4. Strang RR. The association of gastro-duodenal ulceration with Parkinson's disease. Med J Austr 1965 52 : 842 843.
5. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983 1 : 1273 1275.
6. Hung X, Reynolds AD, Mosley RE, Gendelman HE. CD 4+ T cells in the pathobiology of neurodegenerative disorders. J Neuroimmunol 2009 211 : 3 15.
7. Charlett A, Weller C, Dobbs SM, Dobbs RJ. Breadth of base whilst walking: effect of ageing and parkinsonism. Age Ageing 1998 27 : 49 54.
8. Schulz JD, Hawkes EL, Shaw CA. Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denominator. Med Hypotheses 2006 66 : 1222 1226.
9. Mosley RL, Benner EJ, Kadiu I, Thomas M, Boska MD, Hasan K, Laurie C, Gendelman HE. Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson's disease. Clin Neurosci Res 2006 6 : 261 281.
10. Bjarnason IT, Charlett A, Dobbs RJ, et al. Role of chronic infection and inflammation in the gastrointestinal tract in the aetiology and pathogenesis of idiopathic parkinsonism. Part 2: response of facets of clinical idiopathic parkinsonism to Helicobacter pylori eradication. A randomised, double-blind, placebo-controlled efficacy study. Helicobacter 2005 10 : 276 287. (Pubitemid 41104966)
11. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's Disease. Ann Neurol 1992 32 (Suppl. S125 7.
12. Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003 24 : 197 211.
13. Calne DB. Parkinson's disease is not one disease. Parkinsonism Relat Disord 2001 7 : 3 7.
14. Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. In : Pichot T, ed. Psychological Measurements in Psychopharmacology, 7, Modern Problems in Psychiatry.
15. Denham MJ, Jefferys P. Modified Tooting Bec Questionnaire. In : Israël L, Kozarevic D, Sartorius N, eds. Source Book of Geriatric Assessment (vol. 2).
16. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1995 12 : 189 198.
17. Bowes SG, Clark PK, Leeman AL, O'Neill CJA, Weller C, Nicholson PW, Deshmukh AA, Dobbs SM, Dobbs RJ. Determinants of gait in the elderly Parkinsonian on maintenance levodopa/carbidopa therapy. Br J Clin Pharmacol 1990 30 : 13 24.
18. Weller C, O'Neill CJA, Charlett A, Bowes SG, Purkiss A, Nicholson PW, Dobbs RJ, Dobbs SM. Defining small differences in efficacy between anti-Parkinsonian agents using gait analysis: a comparison of two controlled release formulations of levodopa/decarboxylase inhibitor. Brit J Clin Pharmacol 1993 35 : 379 385.
19. Kirollos C, O'Neill CJA, Dobbs RJ, Charlett A, Bowes SG, Purkiss AG, Hunt WB, Dobbs SM. Quantification of the cardinal signs of Parkinsonism and of associated disability in spouses of sufferers. Age Ageing 1993 22 : 20 6.
20. Kirollos C, Charlett A, Bowes SG, et al. Time course of physical and psychological responses to selegiline monotherapy in newly diagnosed, idiopathic parkinsonism. Eur J Clin Pharmacol 1996 50 : 7 18.
21. Bland JM, Altman DG. Statistics notes: Cronbach's alpha. Brit Med J 1997 314 : 572.
22. Dobbs RJ, Bowes SG, Charlett A, Henley M, Frith C, Dickens J, Dobbs SM. Hypothesis: The bradyphrenia of Parkinsonism is a nosological entity. Acta Neurol Scand 1993 87 : 255 261.
23. Dixon MF, Genta RM, Yardley JH, Correa P. Participants International Workshop on Histopathology of gastritis, Houston 1994. Classification and grading of gastritis: the updated Sydney System. Am J Surg Path 1996 20 : 1161 1181.
24. Elviss NC, Owen RJ, Xerry J, Walker AM, Davies K. Helicobacter pylori resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales. J Antimicrob Ther 2004 54 : 435 440.
25. Ho SA, Hoyle JA, Lewis FA, Secker AD, Cross D, Mapstone NP, Dixon MF, Wyatt JI, Tompkins DS, Taylor GR. Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol 1991 29 : 2543 2549.
26. Chisholm SA, Owen RJ, Teare EL, Saverymuttu S. PCR-based diagnosis of Helicobacter pylori infection and real-time determination of clarithromycin resistance directly from human gastric biopsy samples. J Clin Microbiol 2001 39 : 1217 1220.
27. Freeman PR. The role of P-values in analysing trial results. In : Colton T, Freedman LS, Johnson AL, Machin D, eds. Statistics in Medicine (vol. 12).
28. Diggle PJ, Heagerty P, Liang K-Y, Zeger SL. Random effects models. In : Analysis of Longitudinal Data. 2nd Edition. Oxford Statistical Science Series, 25.
29. StataCorp. Stata Statistical Software. Release 10.
30. Atherton JC, Cao P, Peek RM, Tummuru MKR, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995 270 : 17771 17777.
31. Atherton JC, Cover TL, Twells RJ, Morales MR, Hawkey CJ, Blaser MJ. Simple and accurate PCR-based system for typing vacuolating cytotoxin alleles of Helicobacter pylori. J Clin Microbiol 1999 37 : 2979 2982.
32. Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh Hosseini M, Atherton JC. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 2007 133 : 926 936.
33. Rudi J, Kolb C, Maiwald M, Kuck D, Sieg A, Galle PR, Stremmel W. Diversity of Helicobacter pylori vacA and cagA Genes and Relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J Clin Microbiol 1998 36 : 944 948.
34. Sugimoto M, Wu J-Y, Abudayyeh S, Hoffman J, Brahem H, Al-Khatib K, Yamaoka Y, Graham DY. Unreliability of results of PCR detection of Helicobacter pylori in clinical or environmental samples. J Clin Microbiol 2009 47 : 738 742.
35. Rhodes JM, Middleton P, Jewell DP. The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth. Scand J Gastroenterol 1979 14 : 333 336.
36. Weller C, Charlett A, Oxlade NL, Dobbs SM, Dobbs RJ, Peterson DW, Bjarnason IT. Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis in idipopathic parkinsonism. Part 3: predicted probability and gradients of severity of idiopathic parkinsonism based on H. pylori antibody profile. Helicobacter 2005 10 : 288 297. (Pubitemid 41104967)
37. Dobbs RJ, Dobbs SM, Weller C, Bjarnason IT, Oxlade NL, Charlett A, Al-Janabi MA, Kerwin RW, Mahler RF, Price AB. Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis in idipopathic parkinsonism. Part 1: eradication of Helicobacter in the cachexia of idiopathic parkinsonism. Helicobacter 2005 10 : 267 275. (Pubitemid 41104965)
38. Braak H, de Vos RAI, Bohl J, Del Tredici K. Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 2006 396 : 67 72.
39. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2003 2 : 107 116.
40. Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001 57 : 456 462.
41. Charlett A, Dobbs RJ, Weller C, Dobbs SM. Stasis in the gut: the source of xenobiotic in idiopathic parkinsonism. Eur J Clin Pharmacol 1997 52 (Suppl. 168.
42. Kordower JH, Chu Y, Hauser RA, Olanow CW, Freeman TB. Transplanted dopaminergic neurons develop PD pathologic changes: a second case report. Mov Disord 2008 23 : 2303 2306.
43. Vonka V. Causality in medicine: the case of tumours and viruses. Philos Trans R Soc Lond B 2000 335 : 1831 1841.
44. Dobbs RJ, Charlett A, Purkiss AG, Dobbs SM, Weller C, Peterson DW. Association of circulating TNF-α and IL-6 with ageing and parkinsonism. Acta Neurol Scand 1999 100 : 34 41.
45. Ito T, Kobayashi D, Uchida K, et al. Helicobacter pylori invades the gastric mucosa and translocates to the gastric lymph nodes. Lab Invest 2008 88 : 664 681.
46. Charlett A, Dobbs RJ, Purkiss AG, Wright DJ, Peterson DW, Weller C, Dobbs SM. Cortisol is higher in parkinsonism and associated with gait deficit. Acta Neurol Scand 1998 97 : 77 85.
47. Dobbs SM, Dobbs RJ, Curry A, Bjarnason IT, Weller C, Charlett A. Idiopathic parkinsonism as a mitochondrial disease: further evidence for systemic disease, implication of gastrointestinal infection. Helicobacter 2008 13 : 400.
48. Kubo S, Hattori N, Mizono Y. Recessive Parkinson's disease. Mov Disord 2006 21 : 885 893.
49. Wolozin B, Saha S, Guillily M, Ferree A, Riley M. Investigating convergent actions of genes linked to familial Parkinson's disease. Neurodegener Dis 2008 5 : 182 185.
50. Saha S, Guillily M, Ferree A, et al. LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans. J Neurosci 2009 29 : 9210 9218.
51. Wang X, Su B, Zheng L, Perry G, Smith MA, Zhu X. The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J Neurochem 2009 109 : 153 159.
52. Lahner E, Annibale B, Delle Fave G. Systematic review: Helicobacter pylori and impaired drug absorption. Aliment Pharmacol Ther 2009 29 : 379 386.
53. Migneco A, Ojetti V, Specchia L, Franceschi F, Candelli M, Mettimano M, Montebelli R, Savi L, Gasbarrini G. Eradication of Helicobacter pylori infection improves blood pressure values in patients affected by hypertension. Helicobacter 2003 8 : 585 589.